Clinical trial
Antimicrobial Revision in Patients With Persistent Febrile Neutropenia: A Prospective, Randomized Trial
NCT05784844 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antimicrobial Revision in Patients With Persistent Febrile Neutropenia: A Prospective, Randomized Trial
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- August 31, 2024
- Completion date
- April 30, 2025
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.